Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?
Uher, T., Havrdova, E., Sobisek, L., Krasensky, J., Vaneckova, M., Seidl, Z., Tyblova, M., Ramasamy, D., Zivadinov, R., Horakova, D.Language:
english
Journal:
Multiple Sclerosis Journal
DOI:
10.1177/1352458516650525
Date:
May, 2016
File:
PDF, 1.15 MB
english, 2016